SQXlogo
  • My Dashboard
  • Bond Academy
  • Tools
    • Bond Screener
    • Issuer Directory
    • Portfolio Builder
    • Discussion Board
  • Data Partners
‌
‌
  • Home
  • My Dashboard
  • Bond Academy
  • Tools
  • Data Partners
  • LoginCreate a free account
SQX-logo
SQX-white-logo© SQX BONDS. All rights reserved | Privacy Policy | Terms and Conditions | Represent a financial institution? | Customer Support
Visit SQXBonds on linkedinVisit SQXBonds on LinkedInVisit SQXBonds on facebookVisit SQXBonds on LinkedInVisit SQXBonds on instagramVisit SQXBonds on LinkedInVisit SQXBonds on twitterVisit SQXBonds on LinkedInVisit SQXBonds on iplVisit SQXBonds on LinkedIn
←Back

Syneos Health bond | 9.00% 2030-10-01 USD | USU85543AA14

Change % : ▲ +0.048%

View all data FOR FREE!

Create an account today, no credit card required.

Overview

pricing as of 2026-09-11
7.66
9.000
104.597
2030-10-01
USD
107.321/100.965

Analytics

3.270
3.393
13.028
‌
‌
‌
‌

Bond Information

Issue Type
Login
Country
United States
Industry
Login
Region
Login
Maturity Date
2030-10-01
Par Value
1000
Callable
Login
Next Call Date
Login
Call Type
Login
Call Price (%)
Login
Series
Login
Class
Login
Maturity Structure
Login
Amount Outstanding (mil)
1000.00

Coupon Information

Coupon
9
Coupon Type
Login
Coupon Frequency
Login
First Coupon Date
Login
Last Coupon Date
Login

Risk Information

Sinking Fund
Login
Security
Login
Subordination
Login
Debt Type
Login

Issuance Information

Issue Date
Login
Dated Date
Login
Issue Size (mil)
1000.000
Min. Piece
Login
Min. Increment
Login

About the SYNH 9.00% 2030-10-01 USD bond (USU85543AA14)

This Syneos Health Inc corporate bond has a 9.00% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 1000.00 million USD and matures on October 01, 2030 with a last coupon date of FEB 28, 2020.

More bonds from Syneos Health Inc

SYNH 9.00% 2030-10-01 USD

US855170AA41

Pays a 9% coupon and matures on October 01, 2030.

104.81 USD▼ -0.24

About the issuer Syneos Health Inc

Syneos Health Inc, founded in 2018 and headquartered in Morrisville, North Carolina, is a leading biopharmaceutical solutions organization focused on accelerating the delivery of therapies to patients. The company offers a range of services that bridge the gap between clinical development and commercial launch, including clinical research, commercial solutions, and consulting services, aimed at optimizing the drug development process for its clients.